Search Results
CMS Launches Groundbreaking Model to Lower Out of Pocket Expenses for Insulin
Newsroom Press Release
Comparing the InCK & MOM Models
The Integrated Care for Kids (InCK) and Maternal Opioid Misuse (MOM) Models are two new Center for Medicare and Medicaid Innovation (Innovation Center) models designed to improve care delivery for vulnerable Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries, particularly those affected by the nation’s opioid crisis, while improving quality of care and reducing spending.
Newsroom Fact SheetCMS awards funding to combat opioid misuse among expectant mothers and improve care for children impacted by the crisis
Goals are to improve quality of care, increase access to treatment based on state-specific needs, and reduce expenditures
Newsroom Press ReleaseDelay of Inclusion of Territories in Medicaid Drug Rebate Program; Covered Outpatient Drug Interim Final Rule (CMS 2345-IFC3)
On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) published the “Medicaid Program; Covered Outpatient Drug” Final Rule with Comment Period (CMS-2345-FC) in the Federal Register (81 FR 5170).
Newsroom Fact SheetTrump Administration Drives Access to More High-Quality Medicare Plan Choices in 2020
Newsroom Press Release
Trump Administration Drives Down Drug Costs for Seniors
Today, the Centers for Medicare & Medicaid Services (CMS), under the leadership of President Trump, announced that, for the third year in a row, the average basic premium for Medicare Part D prescription drug plans, which cover prescription drugs that beneficiaries pick up at a pharmacy, is projected to decline.
Newsroom Press ReleaseCMS Approves Washington State Plan Amendment Proposal to Allow Supplemental Rebates involving a “Subscription” Model for Prescription Drug Payment in Medicaid
Today, the Centers for Medicare & Medicaid Services (CMS) approved the fourth Medicaid state plan amendment proposal to negotiate supplemental rebate agreements involving value-based purchasing arrangements with drug manufacturers that allows states to link payment for prescription drugs to the value delivered.
Newsroom Press ReleaseClaim Rejection and Denials for Providers on the Preclusion List to begin on April 1, 2019
Newsroom Fact Sheet
CMS Updates Drug Dashboards with Prescription Drug Pricing and Spending Data
This Administration’s version of the drug dashboards adds information on the manufacturers that are responsible for price increases and includes pricing and spending data for thousands more drugs across Medicare Parts B and D and Medicaid.
Newsroom Press Release